ReGenesys’ expertise has been built out over the years and has resulted in the completion of a xenobiotic-free stem cell isolation, expansion and cryopreservation platform for the stem cell products. ReGenesys has optimized use of the Quantum bioreactor for stem cell expansion. Also, ReGenesys has built a strong expertise in stem cell research, molecular and functional characterization, potency testing assays and ’omics-based’ comparability screening and xenobiotic-free stem cell-based process and product development. A potential product similar to MultiStem has been developed by ReGenesys for the veterinary market. Being a member of a regional network for innovative regenerative medicine (RegMed), ReGenesys has a strong focus on tissue engineering and next generation stem cell product development.
For more information https://www.regenesys.eu/